Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, October 28, 2021.
Navidea Biopharmaceuticals, Inc. (AMEX:NAVB)
Long-Term Downtrend (-90) - NAVB is in a strong downtrend that is likely to continue. While NAVB is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid NAVB?
MarketClub looks at technical strength and momentum to determine if the timing is right for NAVB.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for NAVB
The long-term trend has been DOWN since Sep 30th, 2020 at 2.45
The intermediate-term trend has been DOWN since Oct 27th, 2021 at 1.61
The short-term trend has been DOWN since Oct 21st, 2021 at 1.71
Smart Scan Analysis for NAVB
Based on our trend formula, NAVB is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 1.5200 | 1.5680 | 1.5005 | 1.5359 | -0.0141 |
| Prev. Close | Volume | Bid | Ask | Time |
| 1.5500 | 41986 | 2021-10-28 15:58:29 |
| Year High | 0.4242 | Year High Date | 2018-03-09 |
| Year Low | 0.125 | Year Low Date | 2018-08-16 |
| 52wk High | 3.15 | 52wk High Date | 2021-02-09 |
| 52wk Low | 1.29 | 52wk Low Date | 2021-10-27 |
| Year End Close | 2.83 | Average Volume | 66,831 |
| Shares Outstanding | 30,163 | Short Interest | 18,176,460 |
| % Institutional | 24.5 | Market Cap | 13M |
| Assets | 11,281,310M | Liabilities | 5,576,440M |
| P/E Ratio | -3.375 | Beta | 0.92 |
| Volatility | 87.14 |